Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug 14;79(7):668-74.
doi: 10.1212/WNL.0b013e3182648b65. Epub 2012 Jul 18.

Measures of growth in children at risk for Huntington disease

Affiliations

Measures of growth in children at risk for Huntington disease

Jessica K Lee et al. Neurology. .

Abstract

Objective: The effect of mHTT on human development was examined by evaluating measures of growth in children at risk for Huntington disease (HD).

Methods: Children at risk for HD with no manifest symptoms (no juvenile HD included) were enrolled and tested for gene expansion for research purposes only. Measurements of growth (height, weight, body mass index [BMI], and head circumference) in children tested as gene-expanded (n = 20, 7-18 years of age, CAG repeats ≥39) were compared to those of a large database of healthy children (n = 152, 7-18 years of age).

Results: Gene-expanded children had significantly lower measures of head circumference, weight, and BMI. Head circumference was abnormally low even after correcting for height, suggesting a specific deficit in brain growth, rather than a global growth abnormality.

Conclusions: These results indicate that, compared to a control population, children who were estimated to be decades from HD diagnosis have significant differences in growth. Further, they suggest that mHTT may play a role in atypical somatic, and in particular, brain development.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Relationship between height and age
This scatterplot demonstrates the distribution of height by age for each participant including those from both gene-expanded group and combined controls. Both male and female growth trajectories of our current sample closely match the standardized trajectories produced by the Centers for Disease Control and Prevention.
Figure 2
Figure 2. Growth trajectory and Z score of growth measurements of CAG gene-expanded and gene-nonexpanded group
Growth trajectory in (A) height, (B) weight, (C) body mass index (BMI), and (D) head circumference of children with and without CAG gene expansion is depicted. The dashed lines indicate the 95% confidence limits for the fitted trend lines. (E) Findings in growth measurements of children at risk for Huntington disease in comparison with healthy controls. Z score of 0 represents healthy controls.

Comment in

References

    1. Molero AE, Gokhan S, Gonzalez S, Feig JL, Alexandre LC, Mehler MF. Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease. Proc Natl Acad Sci USA 2009; 106: 21900– 21905 - PMC - PubMed
    1. Nopoulos PC, Aylward EH, Ross CA, et al. Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment. Brain 2011; 134: 137– 142 - PMC - PubMed
    1. Orth M, Cooper JM, Bates GP, Schapira AH. Inclusion formation in Huntington's disease R6/2 mouse muscle cultures. J Neurochem 2003; 87: 1– 6 - PubMed
    1. Bhide PG, Day M, Sapp E, et al. Expression of normal and mutant huntingtin in the developing brain. J Neurosci 1996; 16: 5523– 5535 - PMC - PubMed
    1. Farrer LA, Yu PL. Anthropometric discrimination among affected, at-risk, and not-at-risk individuals in families with Huntington disease. Am J Med Genet 1985; 21: 307– 316 - PubMed

Publication types